In addition, the concentration of circulating betatrophin, which increases in NAFLD patients according to the extent of their hepatic steatosis,37, 38 was higher in patients with liver fibrosis than in healthy controls.39 Here, ANGPTL8 is linked to metabolic dysfunction-associated steatotic liver disease.